HTR5A and depressive symptom measurement: Consequently, the 5-HT5A structure provides an accurate template for the rational design of drugs targeting 5-HT5A and may offer a new opportunity for the treatment of nervous system diseases, including psychosis, depression, schizophrenia, and neuropathic pain.